FDA Clears Denifanstat Phase 3 Trial for Moderate to Severe Acne
FDA Clears Denifanstat Phase 3 Trial for Moderate to Severe Acne The Clinical Trial Vanguard
Regulatory Approvals
Samsung gets FDA approval – takes leap into US OTC market
Samsung gets FDA approval – takes leap into US OTC market medwatch.com
US FDA approves Bristol Myers’ blood cancer treatment
US FDA approves Bristol Myers' blood cancer treatment Reuters
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma CancerNetwork
FDA Approves Novel Iberdomide Regimen in RRMM
FDA Approves Novel Iberdomide Regimen in RRMM The American Journal of Managed Care